Literature DB >> 20653809

Feasibility of electroporation for the creation of pulmonary vein ostial lesions.

Fred H Wittkampf1, Vincent J van Driel, Harry van Wessel, Aryan Vink, Irene E Hof, Paul F Gründeman, Richard N W Hauer, Peter Loh.   

Abstract

INTRODUCTION: There is an obvious need for a better energy source for pulmonary vein (PV) antrum isolation.
OBJECTIVE: We investigated the feasibility and safety of electroporation for the creation of PV ostial lesions.
METHODS: After transseptal puncture, a custom 7F decapolar 20 mm circular ablation catheter was placed in the PV ostia of 10 pigs. Ablation was performed with a nonarcing, 200 J application delivered between the catheter and an indifferent patch electrode on the lower back. A single pulse was applied for each catheter position, with a maximum of 4 per ostium. Local PV electrogram amplitude and stimulation threshold were measured at multiple locations in both ostia before and directly after ablation, and after 3 weeks survival, using a regular 4 mm mapping catheter. All PV ostia were sectioned, stained, and histologically investigated.
RESULTS: The 3-week survival period was uneventful. PV ostial electrogram amplitude decreased and stimulation threshold increased significantly in most ostia. PV angiograms did not show any stenosis during this short follow-up. Histologically, up to 3.5-mm-deep lesions were found.
CONCLUSION: Data suggest that electroporation can safely be used to create lesions in a sensitive environment like PV ostia.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20653809     DOI: 10.1111/j.1540-8167.2010.01863.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  9 in total

1.  Electroporation: The End of the Thermal Ablation Era?

Authors:  Sanjiv M Narayan; Tina Baykaner
Journal:  J Am Coll Cardiol       Date:  2019-07-23       Impact factor: 24.094

Review 2.  Pulsed Field Ablation: a Novel Therapeutic Tool for Catheter-Based Treatment of Atrial Fibrillation.

Authors:  Andrew E Darby
Journal:  Curr Cardiol Rep       Date:  2022-05-24       Impact factor: 3.955

Review 3.  Better Lesion Creation And Assessment During Catheter Ablation.

Authors:  Saurabh Kumar; Chirag R Barbhaiya; Samuel Balindger; Roy M John; Laurence M Epstein; Bruce A Koplan; Usha B Tedrow; William G Stevenson; Gregory F Michaud
Journal:  J Atr Fibrillation       Date:  2015-10-31

Review 4.  [Pulmonary vein isolation in atrial fibrillation using pulsed field ablation].

Authors:  F Lindemann; S Nedios; T Seewöster; G Hindricks
Journal:  Herz       Date:  2021-06-17       Impact factor: 1.443

5.  Effect of Twisted Fiber Anisotropy in Cardiac Tissue on Ablation with Pulsed Electric Fields.

Authors:  Fei Xie; Christian W Zemlin
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

6.  Intrapulmonary Vein Ablation Without Stenosis: A Novel Balloon-Based Direct Current Electroporation Approach.

Authors:  Chance M Witt; Alan Sugrue; Deepak Padmanabhan; Vaibhav Vaidya; Sarah Gruba; James Rohl; Christopher V DeSimone; Ammar M Killu; Niyada Naksuk; Joanne Pederson; Scott Suddendorf; Dorothy J Ladewig; Elad Maor; David R Holmes; Suraj Kapa; Samuel J Asirvatham
Journal:  J Am Heart Assoc       Date:  2018-07-09       Impact factor: 5.501

Review 7.  Innovations in Clinical Cardiac Electrophysiology: Challenges and Upcoming Solutions in 2018 and Beyond.

Authors:  Vaibhav R Vaidya; Alan Sugure; Samuel J Asirvatham
Journal:  J Innov Card Rhythm Manag       Date:  2017-12-15

8.  Multielectrode Contact Measurement Can Improve Long-Term Outcome of Pulmonary Vein Isolation Using Circular Single-Pulse Electroporation Ablation.

Authors:  Marijn H A Groen; Vincent J H M van Driel; Kars Neven; Harry van Wessel; Jacques M T de Bakker; Pieter A F Doevendans; Fred H M Wittkampf; Peter Loh; René van Es
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-08-02

9.  Feasibility of selective cardiac ventricular electroporation.

Authors:  Alan Sugrue; Vaibhav R Vaidya; Christopher Livia; Deepak Padmanabhan; Anas Abudan; Ameesh Isath; Tyra Witt; Christopher V DeSimone; Paul Stalboerger; Suraj Kapa; Samuel J Asirvatham; Christopher J McLeod
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.